Spear Bio unveils biomarker tests that spot brain disease early
Biomarker science just got a powerful new set of tools. A biotechnology company focused on ultrasensitive protein detection has taken a significant step forward in the race to identify neurodegenerative diseases earlier and more accurately. Spear Bio introduced three new diagnostic assays at the International Conference on Alzheimer’s and Parkinson’s Diseases, known as AD/PD 2026, […]